In pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hemo Organic has submitted the followings: Unaudited Standalone Financial Results for the quarter ended on December 31,2022 and Limited Review Report.
The above information is a part of company’s filings submitted to BSE.